Psychiatric side effects of levodopa in man.
D000818:Animals; D001921:Brain / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D003072:Cognition Disorders / Q000139:chemically induced*; D003693:Delirium / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D000882:Haplorhini; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced*; D008297:Male; D008745:Methylation; D008781:Methyltyrosines / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced; D051381:Rats; D012725:Sexual Behavior / Q000187:drug effects; D013997:Time Factors
D002395:Catecholamines; D008781:Methyltyrosines; D004295:Dihydroxyphenylalanine; D004298:Dopamine